Crossmark

Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models

Crossref DOI link: https://doi.org/10.1186/s12885-018-4238-4

Published Online: 2018-03-27

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tsai, Susan

McOlash, Laura

Palen, Katie

Johnson, Bryon

Duris, Christine

Yang, Qiuhui

Dwinell, Michael B.

Hunt, Bryan

Evans, Douglas B.

Gershan, Jill

James, Michael A. https://orcid.org/0000-0002-8112-1108
Funding

Funding for this research was provided by:

Batterman Foundation

Ronald Burkland Eich Pancreatic Cancer Research Fund

American Cancer Society (14-247-29-IRG)

WeCare Fund
License Information

Text and Data Mining valid from 2018-03-27
More Information

Article History

Received: 22 March 2017

Accepted: 16 March 2018

First Online: 27 March 2018

Ethics approval and consent to participate

: All procedures involving clinical samples are covered under IRB#PRO00012151 (MCW Surgical Biorepository) and PRO00028870 (preclinical chemosensitivity testing), reviewed by Medical College of Wisconsin/Froedtert Hospital Institutional Review Board #2. All patients provided written informed consent at the time of enrollment.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.